相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Trace amine-associated receptor 1 agonism promotes wakefulness without impairment of cognition in Cynomolgus macaques
Anushka V. Goonawardena et al.
NEUROPSYCHOPHARMACOLOGY (2019)
EFFICACY AND SAFETY OF SEP-363856, A NOVEL PSYCHOTROPIC AGENT WITH A NON-D2 MECHANISM OF ACTION, IN THE TREATMENT OF SCHIZOPHRENIA: A 4-WEEK, RANDOMIZED, PLACEBO-CONTROLLED TRIAL
Kenneth Koblan et al.
SCHIZOPHRENIA BULLETIN (2019)
SEP-363856, a Novel Psychotropic Agent with a Unique, Non-D2 Receptor Mechanism of Action
Nina Dedic et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Activation of trace amine-associated receptor 1 attenuates schedule-induced polydipsia in rats
Ilya Sukhanov et al.
NEUROPHARMACOLOGY (2019)
Pronounced Hyperactivity, Cognitive Dysfunctions, and BDNF Dysregulation in Dopamine Transporter Knock-out Rats
Damiana Leo et al.
JOURNAL OF NEUROSCIENCE (2018)
Methamphetamine-induced impulsivity during chronic methamphetamine treatment in rats: Effects of the TAAR 1 agonist R05263397
Zhaoxia Xue et al.
NEUROPHARMACOLOGY (2018)
Role of trace amine-associated receptor 1 in nicotine's behavioral and neurochemical effects
Jian-Feng Liu et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Trace Amines and Their Receptors
Raul R. Gainetdinov et al.
PHARMACOLOGICAL REVIEWS (2018)
Trace Amine-Associated Receptor 1 Modulates the Locomotor and Sensitization Effects of Nicotine
Ilya Sukhanov et al.
FRONTIERS IN PHARMACOLOGY (2018)
The Case for TAAR1 as a Modulator of Central Nervous System Function
Grazia Rutigliano et al.
FRONTIERS IN PHARMACOLOGY (2018)
The Trace Amine-Associated Receptor 1 Agonist 3-lodothyronamine Induces Biased Signaling at the Serotonin 1 b Receptor
Julia Braeunig et al.
FRONTIERS IN PHARMACOLOGY (2018)
Behavioral Phenotyping of Dopamine Transporter Knockout rats: compulsive Traits, Motor stereotypies, and anhedonia
Stefano Cinque et al.
FRONTIERS IN PSYCHIATRY (2018)
Trace Amine-Associated Receptor | Regulates Wakefulness and EEG Spectral Composition
Michael D. Schwartz et al.
NEUROPSYCHOPHARMACOLOGY (2017)
The Trace Amine-Associated Receptor 1 Agonist RO5256390 Blocks Compulsive, Binge-like Eating in Rats
Antonio Ferragud et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Pharmacology of human trace amine-associated receptors: Therapeutic opportunities and challenges
Mark D. Berry et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Interaction Between the Trace Amine-Associated Receptor 1 and the Dopamine D2 Receptor Controls Cocaine's Neurochemical Actions
Aman Asif-Malik et al.
SCIENTIFIC REPORTS (2017)
Trace Amine-Associated Receptor 1 Agonists as Narcolepsy Therapeutics
Sarah W. Black et al.
BIOLOGICAL PSYCHIATRY (2017)
Novel reinforcement learning paradigm based on response patterning under interval schedules of reinforcement
Christin Schifani et al.
BEHAVIOURAL BRAIN RESEARCH (2017)
Modulation by Trace Amine-Associated Receptor 1 of Experimental Parkinsonism, L-DOPA Responsivity, and Glutamatergic Neurotransmission
Alexandra Alvarsson et al.
JOURNAL OF NEUROSCIENCE (2015)
Postsynaptic D2 dopamine receptor supersensitivity in the striatum of mice lacking TAAR1
Stefano Espinoza et al.
NEUROPHARMACOLOGY (2015)
TAAR1 Modulates Cortical Glutamate NMDA Receptor Function
Stefano Espinoza et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Selective activation of the trace amine-associated receptor 1 decreases cocaine's reinforcing efficacy and prevents cocaine-induced changes in brain reward thresholds
Yue Pei et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2015)
The trace amine-associated receptor 1 modulates methamphetamine's neurochemical and behavioral effects
Rachel Cotter et al.
FRONTIERS IN NEUROSCIENCE (2015)
Role of ionotropic glutamate receptors in delay and probability discounting in the rat
Justin R. Yates et al.
PSYCHOPHARMACOLOGY (2015)
Common misconceptions about data analysis and statistics
Harvey J. Motulsky
PHARMACOLOGY RESEARCH & PERSPECTIVES (2015)
TAAR1-dependent effects of apomorphine in mice
Ilya Sukhanov et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight
F. G. Revel et al.
MOLECULAR PSYCHIATRY (2013)
Trace Amine-Associated Receptor 1 Partial Agonism Reveals Novel Paradigm for Neuropsychiatric Therapeutics
Florent G. Revel et al.
BIOLOGICAL PSYCHIATRY (2012)
Brain-Specific Overexpression of Trace Amine-Associated Receptor I Alters Monoaminergic Neurotransmission and Decreases Sensitivity to Amphetamine
Florent G. Revel et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Statistical analysis of latency outcomes in behavioral experiments
Antje Jahn-Eimermacher et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Genetic Deletion of Trace Amine 1 Receptors Reveals Their Role in Auto-Inhibiting the Actions of Ecstasy (MDMA)
Benjamin Di Cara et al.
JOURNAL OF NEUROSCIENCE (2011)
Functional Interaction between Trace Amine-Associated Receptor 1 and Dopamine D2 Receptor
Stefano Espinoza et al.
MOLECULAR PHARMACOLOGY (2011)
TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity
Florent G. Revel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Amphetamine decreases behavioral inhibition by stimulation of dopamine D-2, but not D-3, receptors
Marcel M. van Gaalen et al.
BEHAVIOURAL PHARMACOLOGY (2009)
Trace amine-associated receptor 1 modulates dopaminergic activity
Lothar Lindemann et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Effects of mGlu1 receptor blockade on working memory, time estimation, and impulsivity in rats
Irina A. Sukhotina et al.
PSYCHOPHARMACOLOGY (2008)
The trace amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia
T. D. Wolinsky et al.
GENES BRAIN AND BEHAVIOR (2007)
Effects of NMDA receptor channel blockers, MK-801 and memantine, on locomotor activity and tolerance to delay of reward in Wistar-Kyoto and spontaneously hypertensive rats
IM Sukhanov et al.
BEHAVIOURAL PHARMACOLOGY (2004)
Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor
JR Bunzow et al.
MOLECULAR PHARMACOLOGY (2001)
Trace amines: Identification of a family of mammalian G protein-coupled receptors
B Borowsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The effects of d-amphetamine, chlordiazepoxide, α-flupenthixol and behavioural manipulations on choice of signalled and unsignalled delayed reinforcement in rats
RN Cardinal et al.
PSYCHOPHARMACOLOGY (2000)
分享论文
